Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Eculizumab for Prevention of Antibody-Mediated Rejection in Blood Group-Incompatible Renal Transplantation.

West-Thielke P, Progar K, Campara M, Jasiak N, Gallon L, Tang I, Spaggiari M, Tzvetanov I, Benedetti E.

Transplant Proc. 2018 Jan - Feb;50(1):66-69. doi: 10.1016/j.transproceed.2017.12.015.

PMID:
29407333
2.

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.

Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD.

Am J Kidney Dis. 2017 Nov 18. pii: S0272-6386(17)30897-1. doi: 10.1053/j.ajkd.2017.07.018. [Epub ahead of print]

3.

LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.

Bunnapradist S, Rostaing L, Alloway RR, West-Thielke P, Denny J, Mulgaonkar S, Budde K.

Transpl Int. 2016 May;29(5):603-11. doi: 10.1111/tri.12770. Epub 2016 Apr 3.

4.

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.

Rostaing L, Bunnapradist S, GrinyĆ³ JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group.

Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22.

5.

Experimental protocol of a randomized controlled clinical trial investigating the effects of personalized exercise rehabilitation on kidney transplant recipients' outcomes.

Kastelz A, Tzvetanov IG, Fernhall B, Shetty A, Gallon L, West-Thielke P, Hachaj G, Grazman M, Benedetti E.

Contemp Clin Trials. 2015 Nov;45(Pt B):170-176. doi: 10.1016/j.cct.2015.10.002. Epub 2015 Oct 22.

PMID:
26475662
6.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.

Langone A, Steinberg SM, Gedaly R, Chan LK, Shah T, Sethi KD, Nigro V, Morgan JC; STRATO Investigators.

Clin Transplant. 2015 Sep;29(9):796-805. doi: 10.1111/ctr.12581. Epub 2015 Aug 6.

7.

Combined Robot-assisted Kidney Transplantation and Sleeve Gastrectomy in a Morbidly Obese Recipient.

Ayloo SM, D'Amico G, West-Thielke P, Bejarano-Pineda L, Tzvetanov I, Giulianotti PC, Benedetti E, Oberholzer J.

Transplantation. 2015 Jul;99(7):1495-8. doi: 10.1097/TP.0000000000000541.

PMID:
25675197
8.

A novel and personalized rehabilitation program for obese kidney transplant recipients.

Tzvetanov I, West-Thielke P, D'Amico G, Johnsen M, Ladik A, Hachaj G, Grazman M, Heller RU, Fernhall B, Daviglus ML, Solaro RJ, Oberholzer J, Gallon L, Benedetti E.

Transplant Proc. 2014 Dec;46(10):3431-7. doi: 10.1016/j.transproceed.2014.05.085.

PMID:
25498067
9.

Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial.

Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group.

Am J Transplant. 2014 Dec;14(12):2796-806. doi: 10.1111/ajt.12955. Epub 2014 Oct 2.

10.

Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial.

Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K; MELT investigators.

Am J Transplant. 2013 Mar;13(3):760-9. doi: 10.1111/ajt.12035. Epub 2012 Dec 21.

11.

Cell population in spleens during antibody-mediated rejection: pathologic and clinical findings.

Tzvetanov I, Spaggiari M, Oberholzer J, Setty S, Stephenson A, Thielke J, West-Thielke P, Jeon H, Danielson KK, Kaplan B, Benedetti E.

Transplantation. 2012 Aug 15;94(3):255-62. doi: 10.1097/TP.0b013e3182562881.

PMID:
22790386
12.

Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST).

Kasiske BL, Israni AK, Snyder JJ, Camarena A; COST Investigators.

Am J Kidney Dis. 2011 Jun;57(6):908-16. doi: 10.1053/j.ajkd.2011.01.020. Epub 2011 Mar 15.

13.

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.

Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J.

Transplantation. 2009 Jan 27;87(2):268-73. doi: 10.1097/TP.0b013e3181919a16.

PMID:
19155983
14.

Reported isolated pancreas rejection is associated with poor kidney outcomes in recipients of a simultaneous pancreas kidney transplant.

Kaplan B, West-Thielke P, Herren H, Gill J, Knoll GA, Oberholzer J, Sankary H, Benedetti E.

Transplantation. 2008 Nov 15;86(9):1229-33. doi: 10.1097/TP.0b013e318188ad11.

PMID:
19005404
15.

ABO incompatible renal transplantation in an HIV-seropositive patient.

Campara M, West-Thielke P, Thielke J, Ommert T, Oberholzer J, Benedetti E, Kaplan B.

Transplantation. 2008 Jul 15;86(1):176-8. doi: 10.1097/TP.0b013e31817cf403.

PMID:
18622297
16.

Results of positive cross-match transplantation in African American renal transplant recipients.

West-Thielke P, Herren H, Thielke J, Oberholzer J, Sankary H, Raofi V, Benedetti E, Kaplan B.

Am J Transplant. 2008 Feb;8(2):348-54. doi: 10.1111/j.1600-6143.2007.02085.x. Epub 2008 Jan 7.

17.

Therapeutic monitoring of mycophenolic acid: is there clinical utility?

West-Thielke P, Kaplan B.

Am J Transplant. 2007 Nov;7(11):2441-2. Epub 2007 Sep 14. No abstract available.

Supplemental Content

Loading ...
Support Center